These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 20113320)

  • 41. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.
    Ciernik IF; Dizendorf E; Baumert BG; Reiner B; Burger C; Davis JB; Lütolf UM; Steinert HC; Von Schulthess GK
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):853-63. PubMed ID: 14529793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of standardized uptake value-based positron emission tomography and computed tomography target volumes in esophageal cancer patients undergoing radiotherapy.
    Vali FS; Nagda S; Hall W; Sinacore J; Gao M; Lee SH; Hong R; Shoup M; Emami B
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1057-63. PubMed ID: 20199850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.
    Thomas L; Lapa C; Bundschuh RA; Polat B; Sonke JJ; Guckenberger M
    Radiother Oncol; 2015 Aug; 116(2):269-75. PubMed ID: 26364886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
    Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.
    Mah K; Caldwell CB; Ung YC; Danjoux CE; Balogh JM; Ganguli SN; Ehrlich LE; Tirona R
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):339-50. PubMed ID: 11872279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
    van Loon J; Siedschlag C; Stroom J; Blauwgeers H; van Suylen RJ; Knegjens J; Rossi M; van Baardwijk A; Boersma L; Klomp H; Vogel W; Burgers S; Gilhuijs K
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):448-56. PubMed ID: 20971575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R; Halama J; Bova D; Sethi A; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma.
    Onal C; Topuk S; Yapar AF; Yavuz M; Topkan E; Yavuz A
    Onkologie; 2013; 36(9):484-90. PubMed ID: 24051924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
    Muijs CT; Beukema JC; Pruim J; Mul VE; Groen H; Plukker JT; Langendijk JA
    Radiother Oncol; 2010 Nov; 97(2):165-71. PubMed ID: 20541273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
    Erdi YE; Rosenzweig K; Erdi AK; Macapinlac HA; Hu YC; Braban LE; Humm JL; Squire OD; Chui CS; Larson SM; Yorke ED
    Radiother Oncol; 2002 Jan; 62(1):51-60. PubMed ID: 11830312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.
    Krengli M; Milia ME; Turri L; Mones E; Bassi MC; Cannillo B; Deantonio L; Sacchetti G; Brambilla M; Inglese E
    Radiat Oncol; 2010 Feb; 5():10. PubMed ID: 20137093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers.
    Ashamalla H; Guirgius A; Bieniek E; Rafla S; Evola A; Goswami G; Oldroyd R; Mokhtar B; Parikh K
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):388-95. PubMed ID: 17324530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
    Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET-CT fusion in radiation management of patients with anorectal tumors.
    Anderson C; Koshy M; Staley C; Esiashvili N; Ghavidel S; Fowler Z; Fox T; Esteves F; Landry J; Godette K
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):155-62. PubMed ID: 17707268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer.
    Guo Y; Li J; Zhang P; Shao Q; Xu M; Li Y
    Medicine (Baltimore); 2017 Jan; 96(1):e5528. PubMed ID: 28072693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
    Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion.
    Riegel AC; Berson AM; Destian S; Ng T; Tena LB; Mitnick RJ; Wong PS
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):726-32. PubMed ID: 16626888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.